|
|
#1
02-02-2015, 09:02 PM
|
|||
|
|||
PARI Snags FDA Approval for eRapid Powered Nebulizer System
PARI Snags FDA Approval for eRapid Powered Nebulizer System
PARI, a company based in*Starnberg, Germany, is the first to receive FDA Approval for an electronic Nebulizer indicated for administration of*Genentech’s Pulmozyme (dornase alfa), a purified solution of recombinant human deoxyribonuclease I (rhDNase), for cystic fibrosis. Because the eRapid Powered Nebulizer prepares the medicine considerably faster, patients can take their ******within two to three minutes rather than between six and eight, helping to improve medication*compliance. The portable device is quiet and can be Powered from the wall, or with standard or rechargeable AA batteries. It comes with two handsets that can be boiled in distilled water to sterilize them, or you can autoclave them if you have access to the tech**logy. “After the successful results of a Phase IV study, we are confident that physicians will see that both pediatric and adult patients favor eRapid based on reduced treatment times, quiet operation, and its small, portable size. We were also happy to see that patients were more satisfied with treatment and eRapid had a positive influence on adherence – good for their overall cystic fibrosis management,” said*Lisa Cambridge,*director of Medical Science and Pharmaceutical Alliances at PARI Respiratory Equipment, Inc, in a statement.  Product page: eRapid Nebulizer System… Press release: FDA Approves Pulmozyme with eRapid Nebulizer… The post PARI Snags FDA Approval for eRapid Powered Nebulizer System appeared first on Medgadget. ??????? ??????: PARI Snags FDA Approval for eRapid Powered Nebulizer System || ??????: rss || ??????: اسم منتداك
|
|
|
العرض الشجري